Shortened mean erythrocyte age in female patients with type 2 diabetes mellitus
暂无分享,去创建一个
T. Iwasaka | M. Koga | Shinya Inada | H. Jinnouchi | T. Okumiya | Y. Ono | H. Ijima
[1] 6. Glycemic Targets , 2016, Diabetes Care.
[2] Oseni Bashiru Shola,et al. Hyperglycaemic Environment: Contribution to the Anaemia Associated with Diabetes Mellitus in Rats Experimentally Induced with Alloxan , 2015 .
[3] Oseni Bashiru Shola,et al. Hyperglycaemic Environment: Contribution to the Anaemia Associated with Diabetes Mellitus in Rats Experimentally Induced with Alloxan , 2015, Anemia.
[4] M. Koga. Glycated albumin; clinical usefulness. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[5] M. Kramer,et al. Raised erythrocyte creatine in patients with pulmonary arterial hypertension--evidence for subclinical hemolysis. , 2012, Respiratory medicine.
[6] T. Sanke,et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values , 2012, Diabetology International.
[7] V. Basevi,et al. Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.
[8] H. Saito,et al. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[9] S. L. Jeffcoate,et al. Diabetes control and complications: the role of glycated haemoglobin, 25 years on , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[10] T. Sugiura,et al. Evaluation of intravascular hemolysis with erythrocyte creatine in patients with cardiac valve prostheses. , 2004, Chest.
[11] F. Nuttall,et al. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. , 2004, Diabetes care.
[12] Mamoru Takahashi,et al. An enzymatic method for the measurement of glycated albumin in biological samples. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[13] L. Bry,et al. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. , 2001, Clinical chemistry.
[14] T. Saibara,et al. Sensitive enzymatic assay for erythrocyte creatine with production of methylene blue. , 1998, Clinical chemistry.
[15] D. McMillan,et al. Lowered membrane fluidity of younger erythrocytes in diabetes. , 1992, Diabetes research and clinical practice.
[16] M. Cohen. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy? , 1988, The Journal of diabetic complications.
[17] E. Neumann,et al. Glycosylated hemoglobins (GHb): an index of red cell survival. , 1982, Blood.
[18] J. Fehr,et al. Comparison of red cell creatine level and reticulocyte count in appraising the severity of hemolytic processes. , 1979, Blood.
[19] P. Gallop,et al. The glycosylation of hemoglobin: relevance to diabetes mellitus. , 1978, Science.
[20] C. Peterson,et al. Reversible hematologic sequelae of diabetes mellitus. , 1977, Annals of internal medicine.
[21] A. Cerami,et al. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. , 1976, The New England journal of medicine.
[22] E. Beutler,et al. Creatine, 2,3-diphosphoglycerate and anemia. , 1971, The New England journal of medicine.
[23] W. J. Griffiths. Creatine and Phosphocreatine in the Human Red Cell , 1968, British journal of haematology.
[24] W. J. Griffiths,et al. The Effect of Age on the Creatine in Red Cells , 1967, British journal of haematology.